These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow. Prescrire Int; 2012 Oct; 21(131):242-8. PubMed ID: 23185849 [TBL] [Abstract][Full Text] [Related]
4. Radiation therapy for prostate cancer increases subsequent risk of bladder and rectal cancer: a population based cohort study. Nieder AM; Porter MP; Soloway MS J Urol; 2008 Nov; 180(5):2005-9; discussion 2009-10. PubMed ID: 18801517 [TBL] [Abstract][Full Text] [Related]
6. The Prostate cancer Intervention Versus Observation Trial:VA/NCI/AHRQ Cooperative Studies Program #407 (PIVOT): design and baseline results of a randomized controlled trial comparing radical prostatectomy to watchful waiting for men with clinically localized prostate cancer. Wilt TJ; Brawer MK; Barry MJ; Jones KM; Kwon Y; Gingrich JR; Aronson WJ; Nsouli I; Iyer P; Cartagena R; Snider G; Roehrborn C; Fox S Contemp Clin Trials; 2009 Jan; 30(1):81-7. PubMed ID: 18783735 [TBL] [Abstract][Full Text] [Related]
7. Localised prostate cancer - current treatment options. Duchesne G Aust Fam Physician; 2011 Oct; 40(10):768-71. PubMed ID: 22003477 [TBL] [Abstract][Full Text] [Related]
9. [Practice guideline 'Prostate cancer: diagnosis and treatment']. de Reijke TM; Battermann JJ; van Moorselaar RJ; de Jong IJ; Visser AP; Burgers JS Ned Tijdschr Geneeskd; 2008 Aug; 152(32):1771-5. PubMed ID: 18754308 [TBL] [Abstract][Full Text] [Related]
10. Is brachytherapy comparable with radical prostatectomy and external-beam radiation for clinically localized prostate cancer? Merrick GS; Butler WM; Lief JH; Dorsey AT Tech Urol; 2001 Mar; 7(1):12-9. PubMed ID: 11272667 [TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life 2 years after treatment with radical prostatectomy, prostate brachytherapy, or external beam radiotherapy in patients with clinically localized prostate cancer. Ferrer M; Suárez JF; Guedea F; Fernández P; Macías V; Mariño A; Hervas A; Herruzo I; Ortiz MJ; Villavicencio H; Craven-Bratle J; Garin O; Aguiló F; Int J Radiat Oncol Biol Phys; 2008 Oct; 72(2):421-32. PubMed ID: 18325680 [TBL] [Abstract][Full Text] [Related]
12. Incidence of urethral stricture after primary treatment for prostate cancer: data From CaPSURE. Elliott SP; Meng MV; Elkin EP; McAninch JW; Duchane J; Carroll PR; J Urol; 2007 Aug; 178(2):529-34; discussion 534. PubMed ID: 17570425 [TBL] [Abstract][Full Text] [Related]
13. [Prostate cancer treatments in Belgium]. Kaitouni MI; Roumeguère T Rev Med Brux; 2009 Sep; 30(4):270-8. PubMed ID: 19899373 [TBL] [Abstract][Full Text] [Related]
14. What PCPs and geriatricians need to know about robotic prostatectomy and organ-confined prostate cancer. Carlucci JR; Nabizada-Pace F; Samadi DB Geriatrics; 2009 Feb; 64(2):8-14. PubMed ID: 19256581 [TBL] [Abstract][Full Text] [Related]
15. Decision analyses in consideration of treatment strategies for patients with biochemical failure after curative therapy on clinically localized prostate cancer in the prostate-specific antigen era. Shimizu F; Igarashi A; Fukuda T; Kawachi Y; Minowada S; Ohashi Y; Fujime M Jpn J Clin Oncol; 2007 Oct; 37(10):763-74. PubMed ID: 17956899 [TBL] [Abstract][Full Text] [Related]
16. Clinical predictors of Gleason score upgrading: implications for patients considering watchful waiting, active surveillance, or brachytherapy. Kulkarni GS; Lockwood G; Evans A; Toi A; Trachtenberg J; Jewett MA; Finelli A; Fleshner NE Cancer; 2007 Jun; 109(12):2432-8. PubMed ID: 17497649 [TBL] [Abstract][Full Text] [Related]
17. Pathological stage distribution in patients treated with radical prostatectomy reflecting the need for protocol-based active surveillance: results from a contemporary European patient cohort. Seiler D; Randazzo M; Klotz L; Grobholz R; Baumgartner M; Isbarn H; Recker F; Kwiatkowski M BJU Int; 2012 Jul; 110(2):195-200. PubMed ID: 22093744 [TBL] [Abstract][Full Text] [Related]
18. Androgen deprivation therapy for localized prostate cancer and the risk of cardiovascular mortality. Tsai HK; D'Amico AV; Sadetsky N; Chen MH; Carroll PR J Natl Cancer Inst; 2007 Oct; 99(20):1516-24. PubMed ID: 17925537 [TBL] [Abstract][Full Text] [Related]
19. Economic analysis of active surveillance for localized prostate cancer. Kim S; Dall'Era MA; Evans CP Curr Opin Urol; 2012 May; 22(3):247-53. PubMed ID: 22388666 [TBL] [Abstract][Full Text] [Related]
20. Outcomes of initially expectantly managed patients with low or intermediate risk screen-detected localized prostate cancer. Bul M; van den Bergh RC; Zhu X; Rannikko A; Vasarainen H; Bangma CH; Schröder FH; Roobol MJ BJU Int; 2012 Dec; 110(11):1672-7. PubMed ID: 22928973 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]